Vice President, Global Program Lead, Franchise Lead – Neurology

Key Responsibilities

• Accountable for maximizing the value of the Neurology portfolio by shaping the end‑to‑end disease strategy.
• Develops Disease Area Portfolio Strategy and sets the end‑to‑end disease strategy in partnership with drug development functions and other functions (including research, commercialization, PDS, and enterprise strategy).
• Accelerates the portfolio and reduces development timelines for the most promising new assets while optimizing revenue and reach of currently marketed products.
• Leads all R&D business development activities for the Neurology portfolio, manages the disease portfolio budget, and makes trade‑off decisions with an enterprise mindset.
• Drives execution of portfolio strategy through leadership of Disease Area Global Program Leads.
• Oversees orchestration of design and execution of globally integrated program strategies, timelines, and budgets from candidate nomination to successful launch, commercialization, and lifecycle management within Neurology.
• Clearly communicates program risks, implications of changes in the competitive landscape, and progress toward key milestones.
• Provides strategic and technical leadership to build a world‑class drug development team while enabling a balance between scientific excellence and operational effectiveness.
• Serves as Global Program Lead (GPL) for one or more programs and acts as the single point of accountability for leading the Global Program Team (GPT) through the design and execution of a global integrated program strategy.
• Engages senior leaders and functional area stakeholders to ensure alignment of program strategy and operational plans under the remit.

• MD, PhD, DVM, PharmD, or equivalent advanced degree of relevance.
• 10+ years of experience in the drug development process and leadership experience in academic or industry settings, including education where applicable.
• Expertise in the drug development process, especially in the late development space, relevant regulatory expectations, and overall drug development principles.
• Proven leadership capability building high‑performing teams, managing large organizations and matrix teams with a successful track record of leading through influence and working across global organizational matrices.
• Deep understanding of basic biology, pharmaceutical optimization, translational medicine, and clinical pharmacology, including exposure‑response relationships and dose selection in early development.
• Working knowledge of all functional areas of exploratory development (e.g., chemistry/biochemistry, CMC), late development, and commercial.
• Ability to create a clear purpose, global vision, strategies, and key priorities for competing successfully in the evolving pharmaceutical and healthcare industry.
• Demonstrated ability to lead a cross‑functional team to execute Development Plans that have a global perspective and focus on product differentiation, including opportunities for data‑driven acceleration.
• Demonstrated ability to assess complex but relatively sparse data sets objectively, make informed decisions and take action in the face of uncertainty.
• Demonstrated ability to successfully present complex programs to senior leaders and influence decision making.
• Demonstrated ability to successfully and effectively communicate, collaborate and work across functional boundaries.
• Strong business and financial acumen to ensure portfolio strategies and investment decisions help accelerate company goals.

Demonstrates expertise in drug development processes, particularly in late development, regulatory expectations, and portfolio strategy execution. Proven ability to lead cross‑functional teams and communicate effectively with senior leaders to drive strategic initiatives in the pharmaceutical industry.